NCT04763109

Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: Nicole Baca · Academic / Other
• Sex: All
• Age: 5 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

This is a single arm pilot trial of a novel whole-body Magnetic Resonance Imaging paired with artificial intelligence intervention, to evaluate feasibility defined as scan-rescan reliability, and to estimate the positive predictive value of changes in Magnetic Resonance Imaging scans from baseline to 12-month visit using an Artificial Intelligence algorithm, among 15 pediatric patients with neurofibromatosis type 1 at Cedars-Sinai Medical Center.

Conditions

• Neurofibromatosis Type 1

Interventions

Type	Name	Description
OTHER	Whole-body Magnetic Resonance Imaging	Whole-body Magnetic Resonance Imaging at baseline, 1 month, and 12 months

Timeline

• Start date: 2022-07-08
• Primary completion: 2026-05-01
• Completion: 2027-05-01
• First posted: 2021-02-21
• Last updated: 2025-09-09

Locations

1 site across 1 country: United States